Download PDF
Zentralbl Chir 2011; 136(05): 399-403
DOI: 10.1055/s-0031-1293139
Aktuelle Chirurgie
Georg Thieme Verlag KG Stuttgart · New York

Klinische Forschung – Stammzelltherapie in der Gefäßmedizin

Sigrid Nikol
Further Information

Publication History

Publication Date:
18 October 2011 (online)

Also available at
    Permissions and Reprints

Seit dem Jahr 2002 gibt es eine Vielzahl von meist kleinen klinischen Studien zur sogenannten Stammzelltherapie mit dem Ziel der Angiogenese. Der nachfolgende Artikel wird den aktuellen Stand der wissenschaftlichen und klinischen Entwicklung auf diesem Gebiet zusammenfassen.

 

  • Literatur

  • 1 Diehm C, Schuster A, Allenberg JR et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004; 172: 95-105
    CrossrefPubMedGoogle Scholar
  • 2 Newman AB, Siscovick DS, Manolio TA et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88: 837-845
    CrossrefPubMedGoogle Scholar
  • 3 Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). . Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 01) 1-75
    CrossrefPubMedGoogle Scholar
  • 4 Conte MS, Bandyk DF, Clowes AW et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006; 43: 742-751 discussion 751
    CrossrefPubMedGoogle Scholar
  • 5 Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296
    CrossrefPubMedGoogle Scholar
  • 6 Plaisance BR, Munir K, Share DA et al. Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry. JACC Cardiovasc Interv 2011; 4: 694-701
    CrossrefPubMedGoogle Scholar
  • 7 Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-967
    CrossrefPubMedGoogle Scholar
  • 8 Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003; 9: 702-712
    CrossrefPubMedGoogle Scholar
  • 9 Matsui K, Yoshioka T, Murakami Y et al. Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease. Circ J 2003; 67: 660-662
    CrossrefPubMedGoogle Scholar
  • 10 Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Lancet 2002; 360: 427-435
    CrossrefPubMedGoogle Scholar
  • 11 Durdu S, Akar AR, Arat M et al. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg 2006; 44: 732-739
    CrossrefPubMedGoogle Scholar
  • 12 Huang PP, Yang XF, Li SZ. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007; 98: 1335-1342
    PubMedGoogle Scholar
  • 13 Huang P, Li S, Han M et al. Autologous transplantation of granulocyte colony stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005; 28: 2155-2160
    CrossrefPubMedGoogle Scholar
  • 14 Huang PP, Yang XF, Li SZ et al. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost 2007; 98: 1335-1342
    PubMedGoogle Scholar
  • 15 Wester T, Jørgensen JJ, Stranden E et al. Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study. Scand J Surg 2008; 97: 56-62
    PubMedGoogle Scholar
  • 16 Esato K, Hamano K, Li TS et al. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant 2002; 11: 747-752
    PubMedGoogle Scholar
  • 17 Saigawa T, Kato K, Ozawa T et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004; 68: 1189-1193
    CrossrefPubMedGoogle Scholar
  • 18 Higashi Y, Kimura M, Hara K et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004; 109: 1215-1218
    CrossrefPubMedGoogle Scholar
  • 19 Miyamoto M, Yasutake M, Takano H et al. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant 2004; 13: 429-437
    CrossrefPubMedGoogle Scholar
  • 20 Nizankowski R, Petriczek T, Skotnicki A et al. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol 2005; 63: 351-360
    PubMedGoogle Scholar
  • 21 Bartsch T, Falke T, Brehm M et al. Transplantation of autologous adult bone marrow stem cells in patients with severe peripheral arterial occlusion disease. Med Klin 2006; 101 (Suppl. 01) 195-197
    PubMedGoogle Scholar
  • 22 Miyamoto K, Nishigami K, Nagaya N et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation 2006; 114: 2679-2684
    CrossrefPubMedGoogle Scholar
  • 23 Kajiguchi M, Kondo T, Izawa H et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007; 71: 196-201
    CrossrefPubMedGoogle Scholar
  • 24 Hernández P, Cortina L, Artaza H. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis 2007; 194: e52-e56
    CrossrefPubMedGoogle Scholar
  • 25 Gu YQ, Zhang J, Guo LR et al. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia. Chin Med J (Engl) 2008; 121: 963-967
    PubMedGoogle Scholar
  • 26 Chochola M, Pytlík R, Kobylka P et al. Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia. Int Angiol 2008; 27: 281-290
    PubMedGoogle Scholar
  • 27 Van Tongeren RB, Hamming JF, Fibbe WE et al. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg 2008; 49: 51-58
    PubMedGoogle Scholar
  • 28 De Vriese AS, Billiet J, Van Droogenbroeck J. Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans. J Intern Med 2008; 263: 395-403
    CrossrefPubMedGoogle Scholar
  • 29 Amann B, Luedemann C, Ratei R et al. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009; 18: 371-380
    CrossrefPubMedGoogle Scholar
  • 30 Procházka V, Gumulec J, Chmelová J et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr Lek 2009; 55: 173-178
    PubMedGoogle Scholar
  • 31 Huang PP, Li SZ, Han MZ et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost 2004; 91: 606-609
    PubMedGoogle Scholar
  • 32 Kawamura A, Horie T, Tsuda I et al. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial 2005; 9: 59-63
    CrossrefPubMedGoogle Scholar
  • 33 Lenk K, Adams V, Lurz P et al. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 2005; 26: 1903-1909
    CrossrefPubMedGoogle Scholar
  • 34 Ishida A, Ohya Y, Sakuda H et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005; 69: 1260-1265
    CrossrefPubMedGoogle Scholar
  • 35 Kawamura A, Horie T, Tsuda I et al. Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs 2006; 9: 226-233
    CrossrefPubMedGoogle Scholar
  • 36 Fukumoto Y, Miyamoto T, Okamura T et al. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 1997; 97: 666-668
    CrossrefPubMedGoogle Scholar
  • 37 Kawachi Y, Watanabe A, Uchida T et al. Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor. Br J Haematol 1996; 94: 413-416
    CrossrefPubMedGoogle Scholar
  • 38 Kuhlmann MT, Kirchhof P, Klocke R et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 2006; 203: 87-97
    CrossrefPubMedGoogle Scholar
  • 39 Hill JM, Zalos G, Halcox JP. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk . N Engl J Med 2003; 348: 593-600
    CrossrefPubMedGoogle Scholar
  • 40 Nikol S. Therapeutische Angiogenese mittels Gen- und Stammzellentherapie bei der peripheren arteriellen Verschlusskrankheit. Dtsch Med Wochenschr 2011; 136: 672-674
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Simons M, Bonow RO, Chronos NA et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation 2000; 102: 73-86
    CrossrefPubMedGoogle Scholar
  • 42 Belch J, Hiatt WR, Baumgartner I et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011; 377: 1929-1937
    CrossrefPubMedGoogle Scholar
  • 43 Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 2010; 103: 696-709
    Article in Thieme ConnectPubMedGoogle Scholar